182 related articles for article (PubMed ID: 20977797)
21. Some new insights in intestinal failure-associated liver disease.
Goulet O; Joly F; Corriol O; Colomb-Jung V
Curr Opin Organ Transplant; 2009 Jun; 14(3):256-61. PubMed ID: 19444108
[TBL] [Abstract][Full Text] [Related]
22. The use of Omegaven in treating parenteral nutrition-associated liver disease.
Park KT; Nespor C; Kerner J
J Perinatol; 2011 Apr; 31 Suppl 1():S57-60. PubMed ID: 21448206
[TBL] [Abstract][Full Text] [Related]
23. Effects of n-3 and n-6 fatty acids on plasma eicosanoids and liver antioxidant enzymes in rats receiving total parenteral nutrition.
Yeh SL; Chang KY; Huang PC; Chen WJ
Nutrition; 1997 Jan; 13(1):32-6. PubMed ID: 9058445
[TBL] [Abstract][Full Text] [Related]
24. Use of Fish Oil Intravenous Lipid Emulsions as Monotherapy in the Pediatric Intestinal Failure Patient: Beyond the Package Insert.
Gura KM; Calkins KL; Puder M
Nutr Clin Pract; 2020 Feb; 35(1):108-118. PubMed ID: 31549454
[TBL] [Abstract][Full Text] [Related]
25. Parenteral fish oil monotherapy in the management of patients with parenteral nutrition-associated liver disease.
de Meijer VE; Gura KM; Meisel JA; Le HD; Puder M
Arch Surg; 2010 Jun; 145(6):547-51. PubMed ID: 20566974
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms for the effects of fish oil lipid emulsions in the management of parenteral nutrition-associated liver disease.
Nandivada P; Cowan E; Carlson SJ; Chang M; Gura KM; Puder M
Prostaglandins Leukot Essent Fatty Acids; 2013 Sep; 89(4):153-8. PubMed ID: 23602846
[TBL] [Abstract][Full Text] [Related]
27. Enteral fish oil for treatment of parenteral nutrition-associated liver disease in six infants with short-bowel syndrome.
Tillman EM; Crill CM; Black DD; Hak EB; Lazar LF; Christensen ML; Huang EY; Helms RA
Pharmacotherapy; 2011 May; 31(5):503-9. PubMed ID: 21923431
[TBL] [Abstract][Full Text] [Related]
28. What is the current role for parenteral lipid emulsions containing omega-3 fatty acids in infants with short bowel syndrome?
Diamond IR; Pencharz PB; Wales PW
Minerva Pediatr; 2009 Jun; 61(3):263-72. PubMed ID: 19461570
[TBL] [Abstract][Full Text] [Related]
29. Parenteral lipids and partial enteral nutrition affect hepatic lipid composition but have limited short term effects on formula-induced necrotizing enterocolitis in preterm piglets.
Vegge A; Thymann T; Lauritzen L; Bering SB; Wiinberg B; Sangild PT
Clin Nutr; 2015 Apr; 34(2):219-28. PubMed ID: 24703629
[TBL] [Abstract][Full Text] [Related]
30. Clinical experience in managing pediatric patients with ultra-short bowel syndrome using omega-3 fatty acid.
Chung PH; Wong KK; Wong RM; Tsoi NS; Chan KL; Tam PK
Eur J Pediatr Surg; 2010 Mar; 20(2):139-42. PubMed ID: 20178080
[TBL] [Abstract][Full Text] [Related]
31. Nutritional management of infants with short bowel syndrome.
Wessel JJ; Kocoshis SA
Semin Perinatol; 2007 Apr; 31(2):104-11. PubMed ID: 17462495
[TBL] [Abstract][Full Text] [Related]
32. Elements of successful intestinal rehabilitation.
Sigalet D; Boctor D; Brindle M; Lam V; Robertson M
J Pediatr Surg; 2011 Jan; 46(1):150-6. PubMed ID: 21238657
[TBL] [Abstract][Full Text] [Related]
33. The rationale for the use of parenteral omega-3 lipids in children with short bowel syndrome and liver disease.
Diamond IR; Sterescu A; Pencharz PB; Wales PW
Pediatr Surg Int; 2008 Jul; 24(7):773-8. PubMed ID: 18504595
[TBL] [Abstract][Full Text] [Related]
34. Intravenous fish oil emulsion attenuates total parenteral nutrition-induced cholestasis in newborn piglets.
Van Aerde JE; Duerksen DR; Gramlich L; Meddings JB; Chan G; Thomson AB; Clandinin MT
Pediatr Res; 1999 Feb; 45(2):202-8. PubMed ID: 10022591
[TBL] [Abstract][Full Text] [Related]
35. Early enteral fat supplementation with microlipid® and fish oil in the treatment of two premature infants with short bowel.
Yang Q; Welch CD; Ayers K; Turner C; Pranikoff T
Neonatology; 2010; 98(4):348-53. PubMed ID: 20980771
[TBL] [Abstract][Full Text] [Related]
36. Higher docosahexaenoic acid, lower arachidonic acid and reduced lipid tolerance with high doses of a lipid emulsion containing 15% fish oil: a randomized clinical trial.
D'Ascenzo R; Savini S; Biagetti C; Bellagamba MP; Marchionni P; Pompilio A; Cogo PE; Carnielli VP
Clin Nutr; 2014 Dec; 33(6):1002-9. PubMed ID: 24525115
[TBL] [Abstract][Full Text] [Related]
37. Intravenous lipids in home parenteral nutrition.
Pironi L; Agostini F; Guidetti M
World Rev Nutr Diet; 2015; 112():141-9. PubMed ID: 25471810
[TBL] [Abstract][Full Text] [Related]
38. Parenteral fish oil as monotherapy for patients with parenteral nutrition-associated liver disease.
de Meijer VE; Gura KM; Meisel JA; Le HD; Puder M
Pediatr Surg Int; 2009 Jan; 25(1):123-4. PubMed ID: 18828026
[No Abstract] [Full Text] [Related]
39. Fish oil-based lipid emulsion in the treatment of parenteral nutrition-associated liver disease.
Cowan E; Nandivada P; Puder M
Curr Opin Pediatr; 2013 Apr; 25(2):193-200. PubMed ID: 23407182
[TBL] [Abstract][Full Text] [Related]
40. A prospective, randomized, controlled study of ω-3 fish oil fat emulsion-based parenteral nutrition for patients following surgical resection of gastric tumors.
Wei Z; Wang W; Chen J; Yang D; Yan R; Cai Q
Nutr J; 2014 Mar; 13():25. PubMed ID: 24655407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
